Resistance mechanisms associated with altered intracellular distribution of anticancer agents

Pharmacology and Therapeutics

Volumn 85, Issue 3, 2000, Pages 217-229

  Larsen, Annette K ^a   Escargueil, Alexandre E ^a   Skladanowski, Andrzej ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Anticancer agents; Intracellular pH; Lung resistance protein; Multidrug resistance protein; P glycoprotein; Vesicular transport and turnover

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; ENKEPHALIN; ETOPOSIDE; GLYCOPROTEIN P; GRAMICIDIN; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PEPSTATIN; QUININE; TRIFLUOPERAZINE; VALINOMYCIN; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; CELL PH; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG TRANSPORT; ENDOSOME; GOLGI COMPLEX; HUMAN; HUMAN CELL; LYSOSOME; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DNA, NEOPLASM; DRUG RESISTANCE, MULTIPLE; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASM PROTEINS; ORGANELLES; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0034104453     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00073-X     Document Type: Conference Paper

References (128)

1. Abbondanza C., Rossi V., Roscigno A., Gallo L., Belsito A., Piluso G., Medici N., Nigro V., Molinari A.M., Moncharmont B., Puca G.A. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell. J Cell Biol. 141:1998;1301-1310.
2. Altan N., Chen Y., Schindler M., Simon S.M. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med. 187:1998;1583-1598.
3. Altenberg G.A., Young G., Horton J.K., Glass D., Beelli J.A., Reuss L. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc Natl Acad Sci USA. 90:1993;9735-9738.
4. Almquist K.C., Loe D.W., Hipfner D.R., Mackie J.E., Cole S.P., Deeley R.G. Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. Cancer Res. 55:1995;102-110.
5. Bae H.R., Verkman A.S. Protein kinase A regulates chloride conductance in endocytic vesicles from proximal tubule. Nature. 348:1990;637-639.
6. Barrand M.A., Robertson K.J., Neo S.-Y., Rhodes T., Wright K.A., Twentyman P.R., Scheper R.J. Localization of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumour cells. Biochem Pharmacol. 50:1995;1725-1729.
7. Bech-Hansen N.J., Till J.E., Ling V. Pleiotropic phenotype of colchicine-resistant CHO cells. cross-resistance and collateral sensitivity J Cell Physiol. 88:1976;23-31.
8. Belhoussine R., Morjani H., Sharonov S., Ploton D., Manfait M. Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes. Int J Cancer. 81:1999;81-89.
9. +-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein. Int J Oncol. 12:1998;711-715. a.
10. +-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells. Leukemia. 12:1998;1539-1544. b.
11. Breuninger L.M., Paul S., Gaughan K., Miki T., Chan A., Aaronson S.A., Kruh G.D. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 55:1995;5342-5347.
12. Callaghan R., Riordan J. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem. 268:1993;16059-16064.
13. Campling B.G., Young L.C., Baer K.A., Lam Y.M., Deeley R.G., Cole S.P., Gerlach J.H. Expression of the MRP and MDR1 multidrug resistance genes in small lung cancer. Clin Cancer Res. 3:1997;115-122.
14. Cardarelli C.O., Aksentijevich I., Pastan I., Gottesman M.M. Differential effects of glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res. 55:1995;1086-1091.
15. Chen Z.S., Furukawa T., Sumizawa T., Ono K., Ueda K., Seto K., Akiyama S.I. ATP-dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Mol Pharmacol. 55:1999;921-928.
16. Coggan J.S., Kovacs I., Thompson S.H. The aminoglycoside G 418 suppresses muscarinic receptor-activated calcium release in stably transfected murine N1E-115 neuroblastoma cells. Neurosci Lett. 170:1994;247-250.
17. Cole S.P.C., Deeley R.G. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays. 20:1998;931-940.
18. Cole S.P.C., Downes H.F., Mirski S.E.L., Clements D.J. Alterations in glutathione and glutathione-related enzymes in a multidrug resistant small cell lung cancer cell line. Mol Pharmacol. 37:1990;192-197.
19. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Steward A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
20. Cole S.P., Sparks E., Fraser K., Loe D.W., Grant C.E., Wilson G.M., Deeley R.G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:1994;5902-5910.
21. Coley H.M., Amos W.B., Twentyman P.R., Workman P. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localization of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer. 67:1993;1316-1323.
22. Côme M.-G., Bettaieb A., Skladanowski A., Larsen A.K., Laurent G. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells influence of drug transport abnormalities. Int J Cancer. 81:1999;580-587. a.
23. Côme M.-G., Skladanowski A., Larsen A.K., Laurent G. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells. Br J Cancer. 79:1999;1090-1097. b.
24. Cornwell M.M., Pastan I., Gottesman M.M. Certain calcium channel blockers bind specifically to multidrug-resistant KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem. 262:1987;2166-2170.
25. Cosson P., de Curtis I., Pouyssegur J., Griffiths G., Davoust J. Low cytoplasmic pH inhibits endocytosis and transport from the trans-Golgi network to the cell surface. J Cell Biol. 108:1989;377-387.
26. Cui Y., Konig J., Buchholz J.K., Spring H., Leier I., Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP-2, permanently expressed in human and canine skin. Mol Pharmacol. 55:1999;929-937.
27. Decorti G., Klugmann F.B., Candussio L., Furlani A., Scarcia V., Baldini L. Uptake of Adriamycin by rat and mouse mast cells and correlation with histamine release. Cancer Res. 49:1989;1921-1926.
28. Dolfini E., Dasdia T., Arancia G., Molinari A., Calcabrini A., Scheper R.J., Flens M.J., Gariboldi M.B., Monti E. Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. Br J Cancer. 76:1997;67-76.
29. Duensing T.D., Slate D.L. Intracellular expression of P-glycoprotein in a human colon tumor cell line. Anticancer Res. 14:1994;13-19.
30. Dunne M.J., Kane C., Shepherd R.M., Sanchez J.A., James R.F.L., Johnson P.R.V., Aynsley-Green A., Lu S., Clement J.P., Lindley K.J., Seino S., Aguilar-Bryan L. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med. 336:1997;703-706.
31. Feller N., Broxterman H.J., Wahrer D.C., Pinedo H.M. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP). no inhibition by intracellular glutathione depletion FEBS Lett. 368:1995;385-388.
32. Flens M.J., Izquierdo M.A., Scheffer G.L., Fritz J.M., Meijer C.J., Scheper R.J., Zaman G.J. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:1994;4557-4563.
33. Flens M.J., Zaman G.J., van der Valk P., Izquierdo M.A., Schroeijers A.B., Scheffer G.L., van der Groep P., de Haas M., Meijer C.J., Scheper R.J. Tissue distribution of the multidrug resistance protein. Am J Pathol. 148:1996;1237-1247.
34. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57:1989;921-930.
35. +-ATPases. J Biol Chem. 274:1999;12951-12954.
36. Gervasoni J.E. Jr., Fields S.Z., Krishna S., Baker M.A., Rosado M., Thuraisamy K., Hindenburg A.A., Taub R.N. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res. 51:1991;4955-4963.
37. Goffeau A. The inventory of all ion and drug ATPases encoded by the yeast genome. Acta Physiol Scand Suppl. 643:1998;297-300.
38. Grant C.E., Valdimarsson G., Hipfner D.R., Almquist K.C., Cole S.P.C., Deeley R.G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:1994;357-361.
39. Hardy S.P., Goodfellow H.R., Valverde M.A., Gill D.R., Sepulveda V., Higgins C.F. Protein kinase C mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J. 14:1995;68-75.
40. Hindenburg A.A., Gervasoni J.E. Jr., Krishna S., Steward V.J., Rosado M., Lutzky J., Bhalla K., Baker M.A., Taub R.N. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res. 49:1989;4607-4614.
41. Hoffman M.M., Roepe P.D. Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression. Biochemistry. 36:1997;11153-11168.
42. Hoffman M.M., Wei L.Y., Roepe P.D. Are altered pHi and membrane potential in hu MDR1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J Gen Physiol. 108:1996;295-313.
43. Homolya L., Hollo Z., Germann U.A., Pastan I., Gottesman M.M., Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem. 269:1993;21493-21496.
44. Howard M., Frizzell R.A., Bedwell D.M. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med. 2:1996;467-469.
45. Huang Y., Ibrado A.M., Reed J.C., Bullock G., Ray S., Tang C., Bhalla K. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia. 11:1997;253-257.
46. Hurwitz S.J., Terashima M., Mizunuma N., Slapak C.A. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells. participation of lysosomes Blood. 89:1997;3745-3754.
47. Izquierdo M.A., Scheffer G.L., Flens M.J., Schroeijers A.B., van der Valk P., Scheper R.J. Major vault protein LRP-related multidrug resistance. Eur J Cancer. 32A:1996;979-984.
48. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP-gene encoded conjugate export pump. Cancer Res. 56:1996;988-994.
49. Jirsch J., Deeley R.G., Cole S.P.C., Stewart A.J., Fedida D. Inwardly rectifying K+ channels and volume-regulated anion channels in multidrug-resistant small cell lung cancer cells. Cancer Res. 53:1993;4156-4160.
50. Juliano R.L., Ling V. A surface glycoprotein modulating drug permeability in Chinese ovary cell mutants. Biochem Biophys Acta. 455:1976;152-162.
51. Kartenbeck J., Leuschner U., Mayer R., Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology. 23:1996;1061-1066.
52. Kelly A., Powis S.H., Kerr L.A., Mockridge I., Elliott T., Bastin J., Uchanska-Ziegler B., Ziegler A., Trowsdale J., Townsend A. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature. 355:1992;641-644.
53. Kelly R.B. Microtubules, membrane traffic, and cell organization. Cell. 61:1990;5-7.
54. Keppler D., Cui Y., Konig J., Leier I., Nies A. Export pumps for anionic conjugates encoded by MRP genes. Adv Enzyme Regul. 39:1999;237-246.
55. Kickhoefer V.A., Rajavel K.S., Scheffer G.L., Dalton W.S., Scheper R.J., Rome L.H. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem. 273:1998;8971-8974.
56. Kim J.H., Lingwood C.A., Williams D.B., Furuya W., Manolson M.F., Grinstein S. Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor. J Cell Biol. 134:1996;1387-1399.
57. Kitazono M., Sumizawa T., Takebayashi Y., Chen Z.-S., Furukawa T., Nagayama S., Tani A., Takao S., Aikou T., Akiyama S.-I. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst. 91:1999;1647-1653.
58. Klohs W.D., Steinkampf R.W. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Mol Pharmacol. 34:1988;180-185.
59. Koike K., Kawabe T., Tanaka T., Toh S., Uchiumi T., Wada M., Akiyama S., Ono M., Kuwano M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res. 57:1997;5475-5479.
60. Kool M., van der Linden M., de Haas M., Baas F., Borst P. Expression of human MRP6, a homologue of the multidrug resistance protein MRP1, in tissues and cancer cells. Cancer Res. 59:1999;175-182. a.
61. Kool M., van der Linden M., de Haas M., Scheffer G.L., de Vree J.M., Smith A.J., Jansen G., Peters G.J., Ponne N., Scheper R.J., Elferink R.P., Baas F., Borst P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA. 96:1999;6914-6919. b.
62. Krishnamachary N., Center M.S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:1993;3658-3661.
63. Larsen A.K., Skladanowski A. Cellular resistance to topoisomerase-targeted drugs. from drug uptake to cell death Biochem Biophys Acta. 1400:1998;257-274.
64. Lautier D., Canitrot Y., Deeley R.G., Cole S.P.C. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol. 52:1996;967-977.
65. Legrand O., Simonin G., Beauchamp-Nicoud A., Zittoun R., Marie J.-P. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood. 94:1999;1046-1056.
66. +-antiport. J Biol Chem. 270:1995;3203-3211.
67. Loe D.W., Steward R.K., Massey T.E., Deeley R.G., Cole S.P.C. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the MRP gene. Mol Pharmacol. 51:1997;1034-1041.
68. Loe D.W., Deeley R.G., Cole S.P. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP). evidence for cotransport with reduced glutathione Cancer Res. 58:1998;5130-5136.
69. +ATPase subunit C is overexpressed in multidrug resistant HL60 cells. Biochem Biophys Res Commun. 182:1992;675-681.
70. Maio J.J., Brown F.L. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity. J Cell Physiol. 149:1991;548-559.
71. +-adenosine triphoshatase activity in multidrug resistance in HL60 cells. J Natl Cancer Inst. 83:1991;1098-1102.
72. Marquardt D., Center M.S. Drug transport mechanisms in HL60 cells isolated for resistance to Adriamycin. evidence for nuclear drug accumulation and redistribution in resistant cells Cancer Res. 52:1992;3157-3163.
73. +ATP-ases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol. 265:1993;C1015-C1029.
74. +-ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol. 57:1999;1037-1046.
75. Maser P., Kaminsky R. Identification of three ABC transporter genes in Trypanosoma brucei spp. Parasitol Res. 84:1998;106-111.
76. Meschini S., Molinari A., Calabrini A., Citro G., Arancia G. Intracellular localization of the antitumor drug Adriamycin in living cultured cells. a confocal microscopy study J. Microsc. 176:1994;204-210.
77. Molinari A., Cianfriglia M., Meschini S., Calcabrini A., Arancia G. P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int J Cancer. 59:1994;789-795.
78. Molinari A., Calcabrini A., Meschini S., Stringaro A., Del Bufalo D., Cianfriglia M., Arancia G. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int J Cancer. 75:1998;885-893.
79. Mukhopadhyay K., Parrack P.K., Bhattacharyya B. The carboxy terminus of the alpha subunit of tubulin regulates its interaction with colchicine. Biochemistry. 29:1990;6845-6850.
80. Park H.J., Makepeace C.M., Lyons J.C., Song C.W. Effect of intracellular acidity and ionomycin on apoptosis in HL-60 cells. Eur J Cancer. 32A:1996;540-546.
81. Paulusma C.C., van Geer M.A., Evers R., Heijn M., Ottenhoff R., Borst P., Oude Elfering R.P. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J. 338:1999;393-401.
82. Perkins M.E., Riojas Y.A., Wu T.W., Le Blancq S.M. CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc Natl Acad Sci USA. 96:1999;5734-5739.
83. Prasad R., De Wergifosse P., Goffeau A., Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet. 27:1995;320-329.
84. Raggers R.J., van Helvoort A., Evers R., van Meer G. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J Cell Sci. 112:1999;415-422.
85. 31P magnetic resonance spectroscopy. Biochem Pharmacol. 57:1999;309-312. a.
86. Raghunand N., Martinez-Zaguilan R., Wright S.H., Gillies R.J. pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol. 57:1999;1047-1058. b.
87. Rappa G., Finch R.A., Sartorelli A.C., Lorico A. New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models. Biochem Pharmacol. 58:1999;557-562.
88. Ringel I., Horwitz S.B. Effect of alkaline pH on taxol-microtubule interactions. J Pharmacol Exp Ther. 259:1991;855-860.
89. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., Drum M.L., Iannuzzi M.C., Collins F.S., Tsui L.-C. Identification of the cystic fibrosis gene. cloning and characterization of complementary DNA Science. 245:1989;1066-1073.
90. Robinson L.J., Roberts W.K., Ling T.T., Lamming D., Sternberg S.S., Roepe P.D. Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblast. Biochemistry. 36:1997;11169-11178.
91. Roepe P.D., Wei L.Y., Cruz J., Carlson D. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells. further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein Biochemistry. 32:1993;11042-11056.
92. Safa A.R., Glover C.J., Meyers M.B., Biedler J.L., Felsted R.L. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem. 261:1986;6137-6140.
93. Sarkadi B., Muller M., Homolya L., Hollo Z., Seprodi J., Germann U.A., Gottesman M.M., Price E.M., Boucher R.C. Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J. 8:1994;766-770.
94. Scheffer G.L., Wijngaard P.L., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J., Clevers H.C., Scheper R.J. The drug resistance-related protein LRP is the major vault protein. Nat Med. 1:1995;578-582.
95. Schindler M., Grabski S., Hoff E., Simon S.M. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in Adriamycin-resistant-resistant cells (MCF-7adr). Biochemistry. 35:1996;2811-2817.
96. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L., Smit J.J., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA. 94:1997;4028-4033.
97. Schlemmer S.R., Sirotnak F.M. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. J Biol Chem. 269:1994;31059-31066.
98. + channel. Proc Natl Acad Sci USA. 96:1999;5310-5315.
99. Sehested M., Skovsgaard T., van Deurs B., Winther-Nielsen H. Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J Natl Cancer Inst. 78:1987;171-179. a.
100. Sehested M., Skovsgaard T., van Deurs B., Winther-Nielsen H. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br J Cancer. 56:1987;747-751. b.
101. Sehested M., Skovsgaard T., Roed H. The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells. Biochem Pharmacol. 37:1988;3305-3310.
102. Seidel A., Hasmann M., Loser R., Bunge A., Schaefer B., Herzig I., Steidtmann K., Dietel M. Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells. Virchows Arch. 426:1995;249-256.
103. Seksek O., Bolard J. Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry. J Cell Sci. 109:1996;257-262.
104. Seksek O., Biwersi J., Verkman A.S. Direct measurement of trans-Golgi pH in living cells and regulation by second messengers. J Biol Chem. 270:1995;4967-4970.
105. Shapiro A.B., Corder A.B., Ling V. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. Eur J Biochem. 250:1997;115-121.
106. Simon S.M. Role of organelle pH in tumor cell biology and drug resistance. Drug Discov Today. 4:1999;32-38.
107. Slapak C.A., Lecerf J.-M., Daniel J.C., Levy S.B. Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts. J Biol Chem. 267:1992;10638-10644.
108. Slapak C.A., Mizunuma N., Kufe D.W. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood. 84:1994;3113-3121.
109. Slapak C.A., Martell R.L., Terashima M., Levy S.B. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP). Biochem Pharmacol. 52:1996;1569-1976.
110. Smyth M.J., Krasovskis E., Sutton V.R., Johnstone R.W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA. 95:1998;7024-7029.
111. Sognier M.A., Zhang Y., Eberle R.L., Sweet K.M., Altenberg G.A., Belli J.A. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol. 48:1994;391-401.
112. Stride B.D., Grant C.E., Loe D.W., Hipfner D.R., Cole S.P.C., Deeley R.G. Pharmacological characterization of the murine and human orthologs of multidrug resistance protein in transfected human embryonic kidney cells. Mol Pharmacol. 52:1997;344-353.
113. Tsuruo T., Iida H., Nojri M., Sukagoshi S., Sakurai Y. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res. 43:1983;2905-2910.
114. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin and vinblastine. Proc Natl Acad Sci USA. 84:1987;3004-3008.
115. Vanhoefer U., Cao S., Minderman H., Toth K., Skenderis B.S., Slovak M.L., Rustum Y.M. D,L-Buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin Cancer Res. 2:1996;1961-1968.
116. van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:1996;507-517.
117. van Helvoort A., Giudici M.L., Thielemans M., van Meer G. Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J Cell Sci. 110:1997;75-83.
118. van Luyn M.J., Muller M., Renes J., Meijer C., Scheper R.J., Nienhuis E.F., Mulder N.H., Jansen P.L., De Vries E.G. Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1. Int J Cancer. 76:1998;55-62.
119. van Veen H.W., Konings W.N. The ABC family of multidrug transporters in microorganisms. Biochim Biophys Acta. 1365:1998;31-36.
120. van Veen H.W., Calllaghan R., Soceneantu L., Sardini A., Konings W.N., Higgins C.F. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature. 391:1998;291-295.
121. Versantvoort C.H.V., Broxterman H.J., Bagrij T., Scheper R.J., Twentyman P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumor cell lines overexpressing multidrug resistance-associated protein. Br J Cancer. 72:1995;82-89.
122. Warren L., Jardillier J.-C., Ordentlich P. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells. Cancer Res. 51:1991;1996-2001.
123. Warren L., Malarska A., Jardillier J.-C. The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells. Cancer Chemother Pharmacol. 35:1995;267-269.
124. Weisburg J.H., Roepe P.D., Dzekunov S., Scheinberg D.A. Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells. J Biol Chem. 274:1999;10877-10888.
125. Wijnholds J., Evers R., van Leusden M.R., Mol C.A., Zaman G.J., Mayer U., Beijnen J.H., van der Valk M., Krimpenfort P., Borst P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med. 3:1997;1275-1279.
126. Willingham M.C., Richert N.D., Cornwell M.M., Tsuruo T., Hamada H., Gottesman M.M., Pastan I.H. Immunocytochemical localization of p170 at the plasma membrane of multidrug-resistant human cells. J Histochem Cytochem. 35:1987;1451-1456.
127. Wolf D.C., Horwitz S.B. P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid. Int J Cancer. 52:1992;141-146.
128. Zaman G.J., Flens M.J., van Leusden M.R., de Haaas M., Mulder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA. 91:1994;8822-8826.